Integrated Microfluidic Devices for 18F Labeled PET Probes in Cancer Imaging

用于癌症成像中 18F 标记 PET 探针的集成微流体装置

基本信息

  • 批准号:
    7904767
  • 负责人:
  • 金额:
    $ 22.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2011-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Positron emission tomography (PET) is a very sensitive non-invasive imaging technology for measuring biochemical processes at a whole body level. One of the major roadblocks which limits the widespread use of this powerful technology in both preclinical and clinical settings is the availability of PET probes. New approaches are needed to enable biologists and clinicians to synthesize a wide range of PET probes. Integrated microfluidic technology with intrinsic advantages of speed, chemical economy, flexibility, user- friendliness, safety, modularity and low cost is a prime technology platform for producing radiolabeled molecular probes. Over the past three years, our research groups have demonstrated that integrated microfluidic devices can be used for efficient production of PET probes. In this proposal, we will create an automated, user-friendly and cost efficient microfluidic platform to facilitate syntheses and labeling of [18F]- labeled PET probes, and several small molecule- and bimolecule-based [18F]-labeled PET probes with sizes ranging from 1 to 10 nm will be produced using these microfluidic platform. Initially, we will develop three separate microfluidic functional modules in parallel, including: (i) An off-chip module for concentration of [18F]fluoride, (ii) the core-a set of digitally controlled microfluidic circuits for reagent mixing, solvent exchange, deprotection and/or functional group transformations. (Here, polyperfluoropolyether (PFPE)-elastomer will be utilized to fabricate this core module to achieve improved chemical inertness and device robustness), and (iii) an in-line purification and characterization system. We will assemble the three functional modules into an integrated device, which will be hosted in a standalone, light- weight, self-shielded hot cell, equipped with a digitally controlled interface. Based on a breadboard concept, we will build two new types of integrated devices with relatively more complicated device configurations to meet the synthetic protocols of two major categories of PET probes, i.e., small molecules and radiolabeled biomolecules. We will simplify and generalize the device design and the module connections to allow "plug-in" device reconfiguration. In parallel, a user-friendly operation interface will be developed for broader implementation of the proposed technology. We will then test the feasibility to quickly build new devices for producing novel PET probes. The resulting [18F]-labeled compounds will be evaluated through our collaborative efforts in our research Institute. This proposal brings together the expertise of eight research groups covering the fields of radiochemistry, microfluidics, polymer materials, device prototyping, molecular imaging and antibody engineering. We envision the success of proposed of research will provide a powerful, universal technology to allow a convenient supply of a wide range of [18F]-labeled PET probes, accelerate the discovery and development processes o new PET probes, and facilitate a broader implementation of PET imaging. PUBLIC HEALTH RELEVANCE: Our idea is to create a modular, automated and user-friendly microfluidic platform capable of synthesizing and labeling known and novel [18F]-labeled positron emission tomography (PET) imaging probes on demand. The long term objective of this proposal is to make [18F]-labeled PET probes easily accessible so that researchers and clinicians can perform a wide range of PET studies targeting specific molecular lesions in cancer.
描述(由申请人提供):正电子发射断层扫描(PET)是一种非常灵敏的非侵入性成像技术,用于测量全身水平的生化过程。限制这种强大技术在临床前和临床环境中广泛使用的主要障碍之一是PET探头的可用性。需要新的方法来使生物学家和临床医生能够合成各种PET探针。集成微流控技术具有快速、化学经济、灵活、用户友好、安全、模块化和低成本等内在优势,是生产放射性标记分子探针的主要技术平台。在过去的三年中,我们的研究小组已经证明,集成微流体设备可以用于高效生产PET探针。在这个提议中,我们将创建一个自动化的,用户友好的和具有成本效益的微流控平台,以促进合成和标记的[18 F]-标记的PET探针,和几个小分子和双分子为基础的[18 F]-标记的PET探针的尺寸范围从1到10 nm将使用这些微流控平台生产。最初,我们将并行开发三个独立的微流控功能模块,包括:(i)用于[18F]氟化物浓缩的芯片外模块,(ii)核心-一组用于试剂混合,溶剂交换,脱保护和/或官能团转换的数字控制微流控回路。(Here,聚全氟聚醚(PFPE)-弹性体将用于制造该核心模块以实现改进的化学惰性和装置稳健性),和(iii)在线纯化和表征系统。我们将把这三个功能模块组装成一个集成设备,该设备将被托管在一个独立的、重量轻的、自屏蔽的热室中,并配备有数字控制接口。基于试验板概念,我们将构建两种新型集成器件,其器件配置相对更复杂,以满足两大类PET探头的合成协议,即,小分子和放射性标记的生物分子。我们将简化和概括设备设计和模块连接,以允许“插入式”设备重新配置。与此同时,将开发一个用户友好的操作界面,以便更广泛地实施拟议的技术。然后,我们将测试快速构建用于生产新型PET探针的新设备的可行性。由此产生的[18F]标记的化合物将通过我们的研究所的合作努力进行评估。该提案汇集了八个研究小组的专业知识,涵盖放射化学,微流体,聚合物材料,设备原型设计,分子成像和抗体工程等领域。我们设想,所提出的研究的成功将提供一种强大的通用技术,允许方便地供应各种各样的[18F]标记的PET探针,加速新PET探针的发现和开发过程,并促进PET成像的更广泛实施。公共卫生关系:我们的想法是创建一个模块化,自动化和用户友好的微流体平台,能够根据需要合成和标记已知和新颖的[18F]标记的正电子发射断层扫描(PET)成像探针。该提案的长期目标是使[18F]标记的PET探针易于获得,以便研究人员和临床医生可以针对癌症中的特定分子病变进行广泛的PET研究。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A small library of DNA-encapsulated supramolecular nanoparticles for targeted gene delivery.
Delivery of intact transcription factor by using self-assembled supramolecular nanoparticles.
  • DOI:
    10.1002/anie.201005740
  • 发表时间:
    2011-03-21
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Liu, Yang;Wang, Hao;Kamei, Ken-ichiro;Yan, Ming;Chen, Kuan-Ju;Yuan, Qinghua;Shi, Linqi;Lu, Yunfeng;Tseng, Hsian-Rong
  • 通讯作者:
    Tseng, Hsian-Rong
Photothermal effects of supramolecularly assembled gold nanoparticles for the targeted treatment of cancer cells.
  • DOI:
    10.1002/anie.201000062
  • 发表时间:
    2010-05-17
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Wang, Shutao;Chen, Kuan-Ju;Wu, Ting-Hsiang;Wang, Hao;Lin, Wei-Yu;Ohashi, Minori;Chiou, Pei-Yu;Tseng, Hsian-Rong
  • 通讯作者:
    Tseng, Hsian-Rong
A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity.
  • DOI:
    10.1016/j.biomaterials.2010.11.043
  • 发表时间:
    2011-03
  • 期刊:
  • 影响因子:
    14
  • 作者:
    Chen, Kuan-Ju;Wolahan, Stephanie M.;Wang, Hao;Hsu, Chao-Hsiung;Chang, Hsing-Wei;Durazo, Armando;Hwang, Lian-Pin;Garcia, Mitch A.;Jiang, Ziyue K.;Wu, Lily;Lin, Yung-Ya;Tseng, Hsian-Rong
  • 通讯作者:
    Tseng, Hsian-Rong
Integrated Microfluidic Reactors.
  • DOI:
    10.1016/j.nantod.2009.10.007
  • 发表时间:
    2009-12
  • 期刊:
  • 影响因子:
    17.4
  • 作者:
    Lin WY;Wang Y;Wang S;Tseng HR
  • 通讯作者:
    Tseng HR
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HSIAN-RONG TSENG其他文献

HSIAN-RONG TSENG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HSIAN-RONG TSENG', 18)}}的其他基金

Molecular and Functional Analysis of Single Circulating Melanoma Cells
单个循环黑色素瘤细胞的分子和功能分析
  • 批准号:
    8655522
  • 财政年份:
    2013
  • 资助金额:
    $ 22.87万
  • 项目类别:
Molecular and Functional Analysis of Single Circulating Melanoma Cells
单个循环黑色素瘤细胞的分子和功能分析
  • 批准号:
    8472161
  • 财政年份:
    2013
  • 资助金额:
    $ 22.87万
  • 项目类别:
Supramolecular Nanoparticle-Based PET Probes for Pretargeted Tumor Imaging
用于预定位肿瘤成像的超分子纳米颗粒 PET 探针
  • 批准号:
    8596818
  • 财政年份:
    2012
  • 资助金额:
    $ 22.87万
  • 项目类别:
Supramolecular Nanoparticle-Based PET Probes for Pretargeted Tumor Imaging
用于预定位肿瘤成像的超分子纳米颗粒 PET 探针
  • 批准号:
    8425970
  • 财政年份:
    2012
  • 资助金额:
    $ 22.87万
  • 项目类别:
Generation of hPSCs Using Reprogramming Proteins-Encapsulated Nanoparticles
使用重编程蛋白封装的纳米颗粒生成 hPSC
  • 批准号:
    8325568
  • 财政年份:
    2011
  • 资助金额:
    $ 22.87万
  • 项目类别:
Advanced Development of An Integrated CTC Enrichment Technology
综合CTC富集技术的先进开发
  • 批准号:
    8332752
  • 财政年份:
    2011
  • 资助金额:
    $ 22.87万
  • 项目类别:
Generation of hPSCs Using Reprogramming Proteins-Encapsulated Nanoparticles
使用重编程蛋白封装的纳米颗粒生成 hPSC
  • 批准号:
    8176809
  • 财政年份:
    2011
  • 资助金额:
    $ 22.87万
  • 项目类别:
Advanced Development of An Integrated CTC Enrichment Technology
综合CTC富集技术的先进开发
  • 批准号:
    8079949
  • 财政年份:
    2011
  • 资助金额:
    $ 22.87万
  • 项目类别:
Advanced Development of An Integrated CTC Enrichment Technology
综合CTC富集技术的先进开发
  • 批准号:
    8526209
  • 财政年份:
    2011
  • 资助金额:
    $ 22.87万
  • 项目类别:
3D-Nanostrcutured Substrates for Detection of Circulating Tumor Cells
用于检测循环肿瘤细胞的 3D 纳米结构基质
  • 批准号:
    8133777
  • 财政年份:
    2010
  • 资助金额:
    $ 22.87万
  • 项目类别:

相似海外基金

ACTG240--ZIDOVUDINE VS 2,3-DIDEHYDRO-3'DEOXYTHYMIDINE IN HIV+ CHILDREN
ACTG240--齐多夫定与 2,3-二氢-3脱氧胸苷治疗 HIV 儿童
  • 批准号:
    6247868
  • 财政年份:
    1997
  • 资助金额:
    $ 22.87万
  • 项目类别:
Synthesis of Deoxythymidine Momophosphate and Glutamyldeoxy Thymidylate By Phage
噬菌体合成脱氧胸苷单磷酸和谷氨酰脱氧胸苷酸
  • 批准号:
    7901803
  • 财政年份:
    1979
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Standard Grant
Regulation of Deoxythymidine Kinase in Mammalian Systems
哺乳动物系统中脱氧胸苷激酶的调节
  • 批准号:
    6928973
  • 财政年份:
    1969
  • 资助金额:
    $ 22.87万
  • 项目类别:
BMY-27857 (2'3'-DIDEHYDRO-3'-DEOXYTHYMIDINE, D4T) ADMINISTERED TO HIV+ PATIENTS
BMY-27857(23-二氢-3-脱氧胸苷,D4T)用于 HIV 患者
  • 批准号:
    3849039
  • 财政年份:
  • 资助金额:
    $ 22.87万
  • 项目类别:
ZIDOVUDINE VS 2',3'DIDEHYDRO-3'DEOXYTHYMIDINE IN CHILDREN
齐多夫定与 2,3二氢-3脱氧胸苷在儿童中的比较
  • 批准号:
    3742272
  • 财政年份:
  • 资助金额:
    $ 22.87万
  • 项目类别:
BMY-27857 (2'3'-DIDEHYDRO-3'-DEOXYTHYMIDINE, D4T) ADMINISTERED TO HIV+ PATIENTS
BMY-27857(23-二氢-3-脱氧胸苷,D4T)用于 HIV 患者
  • 批准号:
    3785276
  • 财政年份:
  • 资助金额:
    $ 22.87万
  • 项目类别:
AZT VS 2',3' DIDEOHYDRO-3'DEOXYTHYMIDINE IN CHILDREN W/HIV INFECTION
AZT 与 2,3 二脱氢-3脱氧胸苷治疗 HIV 感染儿童的比较
  • 批准号:
    5220423
  • 财政年份:
  • 资助金额:
    $ 22.87万
  • 项目类别:
AZT VS 2',3' DIDEOHYDRO-3'DEOXYTHYMIDINE IN CHILDREN W/HIV INFECTION
AZT 与 2,3 二脱氢-3脱氧胸苷治疗 HIV 感染儿童的比较
  • 批准号:
    2481037
  • 财政年份:
  • 资助金额:
    $ 22.87万
  • 项目类别:
ZIDOVUDINE VS 2,3-DIDEHYDRO-3 DEOXYTHYMIDINE IN HIV+ CHILDREN
齐多夫定 VS 2,3-二氢-3 脱氧胸苷治疗 HIV 儿童
  • 批准号:
    5220083
  • 财政年份:
  • 资助金额:
    $ 22.87万
  • 项目类别:
BMY-27857 (2'3'-DIDEHYDRO-3'-DEOXYTHYMIDINE, D4T) ADMINISTERED TO HIV+ PATIENTS
BMY-27857(23-二氢-3-脱氧胸苷,D4T)用于 HIV 患者
  • 批准号:
    3763201
  • 财政年份:
  • 资助金额:
    $ 22.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了